These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31182688)

  • 1. CD93 is Selectively Expressed on Human Myeloma Cells but Not on B Lymphocytes.
    Fakhari S; Bashiri H; Ghaderi B; Tari K; Jalili A
    Iran J Immunol; 2019 Jun; 16(2):142-150. PubMed ID: 31182688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
    Ikewaki N; Yamao H; Kulski JK; Inoko H
    J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
    Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y
    Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances.
    Ikewaki N; Tamauchi H; Inoko H
    Microbiol Immunol; 2007; 51(12):1189-200. PubMed ID: 18094537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche.
    Chevrier S; Genton C; Kallies A; Karnowski A; Otten LA; Malissen B; Malissen M; Botto M; Corcoran LM; Nutt SL; Acha-Orbea H
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3895-900. PubMed ID: 19228948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
    Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
    Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning.
    Steinberger P; Szekeres A; Wille S; Stöckl J; Selenko N; Prager E; Staffler G; Madic O; Stockinger H; Knapp W
    J Leukoc Biol; 2002 Jan; 71(1):133-40. PubMed ID: 11781389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.
    Luque R; Brieva JA; Moreno A; Manzanal A; Escribano L; Villarrubia J; Velasco JL; López-Jiménez J; Cerveró C; Otero MJ; Martínez J; Bellas C; Roldán E
    Clin Exp Immunol; 1998 Jun; 112(3):410-8. PubMed ID: 9649209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
    Greenlee-Wacker MC; Briseño C; Galvan M; Moriel G; Velázquez P; Bohlson SS
    J Immunol; 2011 Sep; 187(6):3353-61. PubMed ID: 21849679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
    Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M
    J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of CD93 cell surface expression by protein kinase C isoenzymes.
    Ikewaki N; Kulski JK; Inoko H
    Microbiol Immunol; 2006; 50(2):93-103. PubMed ID: 16490927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
    Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
    Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
    Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
    J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
    Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
    J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
    Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
    Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma.
    Bohlson SS; Silva R; Fonseca MI; Tenner AJ
    J Immunol; 2005 Jul; 175(2):1239-47. PubMed ID: 16002728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.